¡¡
¡¡
¡¡
 
¡¡
Press Releases
Lotus Pharmaceuticals Enter R-Bambuterol® Clinical Trial I 2010/08/26
Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 2010/08/16
Lotus Completed R-Bambuterol¡¯s Pilot Scale Production for Clinical Trials 2010/08/03
Lotus Pharmaceuticals Terminates SEDA 2010/07/22
Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results 2010/05/14
Lotus Pharmaceuticals¡¯ Laevo-Bambuterol Received SFDA Approval to Commence Clinical Trials 2010/04/29
Lotus Pharmaceuticals¡¯ Innovative Drug to Receive SFDA Fast Track Approval  2010/04/20
Lotus Pharmaceuticals, Inc. Reports Full Year 2009 Financial Results  2010/04/01
Lotus Pharmaceuticals Reports Groundbreaking Ceremony  2010/03/10
YA Global Master SPV Ltd Invests up to US$10,000,000 in Lotus Pharmaceutical, Inc. through Equity Line Facility  2010/03/03
Lotus Pharmaceuticals Announces New Prescription Drugs  2010/03/02
Lotus Pharmaceuticals to Commence Sarbanes-Oxley Compliance Project  2010/03/01
Lotus Pharmaceuticals Announces Key Changes   2010/01/15
Lotus Pharmaceuticals, Inc. Appoints OTC Division Head   2009/12/10
Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores  2009/11/30
Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA  2009/11/24
Lotus Pharmaceuticals,Inc. Reports Third-Quarter 2009 Results   2009/11/16
Lotus Pharmaceuticals,Inc. Announces Certain Clarification  2009/11/05
Lotus Pharmaceuticals, Inc. Announces 2010 Growth Strategy 2009/10/19
Lotus Reports Second Quarter 2009 Financial Results 2009/08/14
Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets 2009/07/30
Lotus Pharmaceuticals, Inc. Again Awarded GSP Certification 2009/06/29
Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 2009/05/18
Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 2009/04/22
Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug 2009/02/18
Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs  2009/02/05
Lotus Pharmaceuticals Announces Third Quarter 2008 Results 2008/11/18
Lotus Pharmaceuticals Announces Second Quarter 2008 Results 2008/08/18
Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008 2008/05/30
Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg 2008/04/24
Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 2008/04/17
Lotus Pharmaceuticals Raises $5 Million in Private Placement  2008/02/26
Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies  2008/02/07
Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets 2008/02/26
¡¡ ¡¡
¡¡ Copyright © 2009 Lotus Pharmaceuticals, Inc. All Rights Reserved..
Home Contact